Download PDF
Thromb Haemost 1998; 80(05): 865-866
DOI: 10.1055/s-0037-1615377
Letters to the Editor
Schattauer GmbH

Monitoring the Effect of Heparin Bolus during Percutaneous Coronary Angioplasty (PTCA): Assessment of Three Bedside Coagulation Monitors

N. Hézard
1   From the Laboratoire d’Hématologie and Service de Cardiologie, CHU Robert Debré, Reims, France
,
D. Metz
2   From the Service de Cardiologie, CHU Robert Debré, Reims, France
,
G. Potron
1   From the Laboratoire d’Hématologie and Service de Cardiologie, CHU Robert Debré, Reims, France
,
P. Nazeyrollas
2   From the Service de Cardiologie, CHU Robert Debré, Reims, France
,
D. Maes
2   From the Service de Cardiologie, CHU Robert Debré, Reims, France
,
C. Droulle
1   From the Laboratoire d’Hématologie and Service de Cardiologie, CHU Robert Debré, Reims, France
,
M. C. Mulpas
1   From the Laboratoire d’Hématologie and Service de Cardiologie, CHU Robert Debré, Reims, France
,
J. Elaerts
2   From the Service de Cardiologie, CHU Robert Debré, Reims, France
,
P. Nguyen
1   From the Laboratoire d’Hématologie and Service de Cardiologie, CHU Robert Debré, Reims, France
› Author Affiliations
Further Information

Publication History

Received 22 April 1998

Accepted after resubmision 04 August 1998

Publication Date:
07 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Grill HP, Spero JE, Granato JE. Comparison of activated partial thromboplastin time to activated clotting time for adequancy of heparin anticoagulation just before percutaneous coronary angioplasty. Am J Cardiol 1993; 71: 1219-20.
    CrossrefPubMedGoogle Scholar
  • 2 Rath B, Bennet DH. Monitoring the effect of heparin by measurement of activated clotting time during and after transluminal coronary angioplasty. Br Heart J 1990; 63: 18-21.
    CrossrefPubMedGoogle Scholar
  • 3 Narins CR, Hillegass WB, Nelson CL, Tcheng JE, Harrington RA, Phillips HR, Stack RS, Califf RM. Relation between activated clotting time during angioplasty and abrupt closure. Circulation 1996; 93: 667-71.
    CrossrefPubMedGoogle Scholar
  • 4 Avendano A, Fergusson JJ. Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994; 23: 907-10.
    CrossrefPubMedGoogle Scholar
  • 5 Metz D, Urban P, Hoang V, Camenzind E, Chatelain P, Meier B. Predicting ischemic complications after bailout stenting following failed coronary angioplasty. Am J Cardiol 1994; 74: 271-4.
    CrossrefPubMedGoogle Scholar
  • 6 The EPILOG investigators.. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revacularization. N Engl J Med 1998; 336: 1689-96.
    PubMedGoogle Scholar
  • 7 Indices of reproducibility. In: Methods in observational epidemiology. Kelsey JL, Thompson WD, Evans AS. eds. Oxford University Press; 1986. 10 288-92.
    Google Scholar
  • 8 The APTT monitoring of heparin. The ISTH/ICSH collaborative study. Van der Velde EA, Poller L. Thromb Hemost 1995; 73: 73-81.
    Article in Thieme ConnectPubMedGoogle Scholar